Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Status:
Unknown status
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
Hair loss occurs commonly as a result of radiotherapy administered to the brain, and this can
contribute to the distress and social isolation of patients with advanced cancer. In this
study a topical gel will be applied directly to the scalp during each dose of radiotherapy.
The goal is to determine to what extent the experimental drug is successful in lessening the
hair loss.